Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pituitary Neoplasms 1Pancreatitis 1Pancreatic Neoplasms 1Pancreatic Intraductal Neoplasms 1Pancreatic Fistula 1Leukemia, Biphenotypic, Acute 1Fistula 1Duodenal Neoplasms 1Craniopharyngioma 1

Interventions

Gemcitabine 3Ethanol 3fish oil triglycerides 2S 1 (combination) 2Metronidazole 2Long-Term Synaptic Depression 2Dexamethasone 2pembrolizumab 1pasireotide 1nimotuzumab 1ferumoxtran-10 1alanylglutamine 1Tobacco Use Cessation Devices 1TachoSil 1Sunitinib 1Psychiatric Rehabilitation 1Pregabalin 1Polymerase Chain Reaction 1Polygeline 1Parenteral Nutrition 1Pancrelipase 1Oxaliplatin 1Nutritional Status 1Needles 1Mirtazapine 1Midazolam 1Meperidine 1Immunonutrition Diet 1Hydrocortisone 1Glucocorticoids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Pancreatic Neoplasms × Hydrocortisone × Clear all
NCT02775227 2020-08-24

HYPAR

Helsinki University Central Hospital

Phase 4 Active not recruiting
126 enrolled
Gastrointestinal

Pancreatic Fistula, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡